78% of Nurse Practitioners want to start their own businesses. 🔥 Almost none of them ever did, because the system made it nearly impossible. That is the problem Corner Health was built to solve. Co-founders Lava Sunder and Anne Gifford spent years talking to NPs. What they found was consistent: NPs are wildly entrepreneurial, deeply capable, and completely constrained by the administrative weight of running a practice. Billing. Insurance. Scheduling. Lab orders. Referrals. Patient communication. Without a team behind them, none of it was manageable alone. Corner Health eliminates that constraint. The company is not a consumer brand. It is an operating layer, one that lets NPs function as solo practitioners without hiring a single support staff member. Corner's AI ...

61 percent of America's most financially vulnerable hospitals are in cities. 🏙️ That number stopped me cold when I read it. Everyone in this space has been told the same story for the past year. The cuts hurt rural hospitals. Rural communities. Rural patients. And yes, that is true and it is devastating. But new research cited by The American Prospect is cracking that narrative open. National Nurses United identified 602 financially vulnerable hospitals across 47 states. Together, they are running an aggregated deficit of about $10.2 billion right now. When the full impact of the One Big Beautiful Bill Act hits, researchers project that deficit will balloon to between $15.4 billion and $17.9 billion. ⚠️ And 366 of those ...

Everyone is calling this an FDA approval. It is not. And the difference should shape every radiology AI decision you make in the next 12 months. Aidoc just received FDA Breakthrough Device Designation for First Read, its AI tool that analyzes chest radiographs and generates preliminary radiology report text. The story is everywhere this week. And almost everyone is getting the headline wrong. Breakthrough Device Designation is not clearance. It is not approval. According to DIEurope, Aidoc itself confirmed that First Read remains an investigational device and has not been cleared or approved by the FDA. What it actually means: - The FDA has determined that First Read addresses an unmet clinical need - It qualifies for expedited review, meaning ...

Are you still billing fee-for-service in 2026? 🏥 If you are, CMS just told you exactly what they think of that. On July 14, CMS dropped the proposed Physician Fee Schedule for Calendar Year 2027. And buried inside a dense regulatory document is a message that every physician practice, FQHC CEO, and health system CFO needs to hear right now. The gap between those inside value-based care and those outside it just got wider. Here is what the proposed rule actually says, according to the CMS fact sheet: - Qualifying APM participants (QPs) get a +0.75% conversion factor update for CY 2027 - Non-QPs get only a +0.25% update - The proposed QP conversion factor drops to $33.17, a decrease ...

The world has a third-largest Ebola outbreak. Right now. And most people in healthcare have barely looked up from their inboxes. According to The Analyst Desk, the Ebola outbreak in the Democratic Republic of Congo, caused by the Bundibugyo strain, just became the third-largest Ebola outbreak on record. Cases climbed from roughly 1,460 cases and 452 deaths in early July to 1,947 cases and 704 deaths by July 9. That is the death count rising by roughly 50 in 100 in about ten days. 🌍 Let that number sink in for a second. ⚠️ Here is what the data actually shows: - Case-fatality rate stands near 34 in 100, meaning close to 1 in 3 confirmed patients has died - ...

More FDA clearances in radiology AI should mean safer imaging. It does not. The number on the scoreboard looks impressive. According to AI Certs, academic analysts verified 950 cleared AI tools as of August 2024, and industry media now cite 1,400 to 1,500 authorizations through mid-2026. Radiology captures roughly 70% of that entire list. Chest imaging triage and intracranial hemorrhage detection lead the pack. We are winning the clearance race. We may be losing the evidence race. Here is the part that should make every health system pause: A JAMA Health Forum study mapped 182 recall events across 60 cleared tools. Nearly half of those recalls occurred within twelve months of authorization. Researcher Tinglong Dai called the findings "stunning." And ...

$110 million just went into fixing Medicare. Here is why that matters. Pearl Health raised $50 million in Series C equity and locked in a $60 million credit facility, according to Startup Geek citing Axios Pro Rata. The lead investor is Andreessen Horowitz. Viking Global Investors, AlleyCorp, and Ulysses Capital also participated. This is not just another health tech raise. This is a bet on a specific, hard problem. Pearl Health builds the operating system for value-based care in Medicare. Their platform synthesizes claims data, ADT feeds, and EHR data to identify which patients need attention before costs spiral, guide care teams on next steps, and automate the administrative work that burns out clinicians. Here is what they have built ...

86 FDA AI clearances in one quarter. Most people read this wrong. I read the Innolitics Q2 2026 AI/ML FDA clearance breakdown and stopped at one line: 84 of those came through 510(k), but only 12 were Special 510(k)s. That small number is the entire story. Here is why that distinction matters more than the headline count. According to Innolitics, FDA authorized 86 AI/ML devices in Q2 2026. Radiology led with 59 records. That sounds like momentum. But if you are building or buying AI for your imaging workflow, the total authorization count is almost irrelevant. What matters is how these products evolve after first clearance. I call this The 4-Stage AI Device Maturity Stack. Use it to evaluate any ...

Everyone says this is a budget bill. It is not. For every FQHC director, community health worker, and safety-net provider reading this, H.R.1 is a patient volume crisis arriving in slow motion. A pregnant woman shows up at a community health center. She applied for Medicaid after her first prenatal visit. Under the old rules, her coverage could be backdated two months to cover care she already received. Under H.R.1, that window is now one month for Medicaid expansion enrollees. The bills for that first visit, and anything else before her application date, now fall on her. That is not an edge case. That is the new normal. According to the National Consumers League, here is what H.R.1 actually does ...